FindTrial
Sign In

A study on histopathological changes in placentas of COVID-19 positive mothers.

A study on histopathological changes in placentas of COVID-19 positive mothers.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/02/040157
Enrollment
30
Registered
2022-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Sreelakshmi S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All pregnant females who are corona positive (RT-PCR) and admitted in Obstetrics and Gynecology Dept of KIMS for delivery will be included.

Exclusion criteria

Exclusion criteria: Pregnant ladies with Twin pregnancy or other multiples.

Design outcomes

Primary

MeasureTime frame
To study and characterise the histopathologic findings in the placentas of women with corona virus disease 2019 (COVID-19).Timepoint: 2 YEARS—

Secondary

MeasureTime frame
To correlate the pathological findings with clinical manifestation and delivery outcomes.Timepoint: 2 YEARS—

Countries

India

Contacts

Public ContactSreelakshmi S

Kalinga Institute Of Medical Sciences

sukanta@kims.ac.in7847051099

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026